Dysautonomia International

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Purpose

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

Condition

Glaucoma

Eligibility

Eligible Ages: Over 35 Years
Eligible Sex: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Diagnosis of primary open-angle glaucoma - Phakic or pseudophakic - Age 35 years or older

Exclusion Criteria

Traumatic, uveitic, neovascular, angle-closure glaucoma or - glaucoma associated with vascular disorders - Active corneal inflammation or edema - Retinal disorders not associated with glaucoma

Study Design

Phase: N/A
Study Type: Interventional
Allocation: N/A
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Masking: None (Open Label)

Arm Groups

Arm	Description	Assigned Intervention
Experimental iStent Infinite	iStent Infinite Trabecular Micro-Bypass System	Device: iStent Infinite iStent Infinite Trabecular Micro-Bypass System

Recruiting Locations

Glaukos Investigator Site
Cincinnati, Ohio 45242

Contact:
Dari Parizadeh

More Details

Status: Recruiting
Sponsor: Glaukos Corporation

Study Contact

Dari Parizadeh
949-481-0575
dparizadeh@glaukos.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.